One-third of children with HIV who received very early ART had no detectable virus in their body for at least 12 weeks after stopping treatment, according to study findings. It was another sign that ...
A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could ...
A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment medications – bictegravir and ...
FINDING COULD CHANGE TREATMENTS. MINDY. DEB, 54. NEWBORNS FROM AROUND THE WORLD RECEIVED ANTIRETROVIRAL THERAPY WITHIN 48 HOURS AFTER THEY WERE BORN, USUALLY, DOCTORS WAIT WEEKS OR EVEN MONTHS AFTER ...